Safety Reporting Requirements for INDs and BA/BE Studies: Guidance for Industry and Investigators
Detailed guidance document from FDA and regulatory agencies.
Document Details
Small Entity Compliance Guide
December 20, 2012
April 24, 2020
5e899308-bd5d-4267-9d7e-71f434a2b8db
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Small Entity Compliance GuideMay 15, 2012Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Small Entity Compliance GuideNovember 20, 2012Center for Drug Evaluation and Research
Safety Reporting Requirements for INDs (Investigational New Drug Applications) and BA/BE (Bioavailability/Bioequivalence) Studies: Guidance for Industry and Investigators
Small Entity Compliance GuideDecember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.